TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
RNXT

RenovoRx Inc

Healthcare · Biotechnology

1.60$ +1.3% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RNXT
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.8% 99.8% 100.0% 100.0% 100.0% 96.4% 97.5%
92.7% 93.8% 93.3% 60.4% 80.0% 88.1% 86.8%
92.7% 93.8% 93.3% 88.6% 80.0% 88.1% 86.8%
– – – – 0.0% 0.5% 1.7%
– – – – – 0.0% 2.3%
– – 0.0% – – – –
35.5% 865.7% 5.8% 15.2% 304.6% 44.8% 33.0%
35.5% 214.0% 5.8% 15.2% 80.2% 23.5% 24.2%
– 144.6% – – – 0.8% 1.3%
23.7% 8.5% 3.2% 7.4% 38.3% 7.2% 9.9%
– 1.2% – – – – –
64.5% -765.7% 94.2% 84.8% -204.6% 55.2% 67.0%
-491.7% -781.6% -130.7% -429.1% -2,824.4% -618.6% -758.3%
763.2% 905.1% 109.7% 249.2% 1,403.9% 290.8% 436.5%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?